Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Assessment of lower respiratory tract microbiota associated with pulmonary tuberculosis in children

Altered Intestinal Microbiota and Fecal Metabolites in Patients with Latent and Active Pulmonary Tuberculosis

Lung Microbiome in Children with Hematological Malignancies and Lower Respiratory Tract Infections.

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Characterization of Gut Microbiota in Children with Pulmonary Tuberculosis.

The Relationship Between Lower Respiratory Tract Microbiome and Allergic Respiratory Tract Diseases in Children

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

Introduction to the Database “efficacy of Different Treatment Modalities for Lower Respiratory Tract Infections in Children”

Distinct Lung Microbial Community States in Patients with Pulmonary Tuberculosis

Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States

Airway microbiota in children with bronchial mucus plugs caused by Mycoplasma pneumoniae pneumonia

The Concordance Between Upper and Lower Respiratory Microbiota in Children with Mycoplasma Pneumoniae Pneumonia

Metagenomic Analysis of the Lung Microbiome in Pulmonary Tuberculosis-a Pilot Study

Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study

Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis

Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis

Bronchoalveolar Lavage Fluid Microbiota Dysbiosis in Infants with Protracted Bacterial Bronchitis

Complex sputum microbial composition in patients with pulmonary tuberculosis

[A Comparative Study on the Difference of Gut Microbiota and Its Biomarkers Between Patients with Pulmonary Tuberculosis and Healthy Controls].

Altered intestinal microbiota in children with bronchiolitis

Sputum Microbiota Associated With New, Recurrent And Treatment Failure Tuberculosis